Polar Capital’s Pediatrix Medical MD Stock Holding History

Polar Capital’s Portfolio MD Stock Details MD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-488,472	Closed	-$33.9M	–	254
2017 Q1	$33.9M	Buy	488,472 +84,278	+21%	+$5.85M	0.51%	63
2016 Q4	$26.9M	Buy	+404,194	New	+$26.3M	0.43%	70
2016 Q1	–	Sell	-225,000	Closed	-$16.1M	–	276
2015 Q4	$16.1M	Buy	225,000 +25,000	+13%	+$1.85M	0.29%	101
2015 Q3	$15.4M	Buy	+200,000	New	+$16.1M	0.31%	105
2014 Q2	–	Sell	-370,000	Closed	-$22.9M	–	276
2014 Q1	$22.9M	Buy	370,000 +40,000	+12%	+$2.33M	0.52%	62
2013 Q4	$17.6M	Buy	+330,000	New	+$17.7M	0.42%	83

Other funds holding MD

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

TSW

Thompson Siegel & Walmsley Richmond, Virginia $5.7B AUM 6.69% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Polar Capital's MD Position: Q2 2017 in Review

Polar Capital sold out of Pediatrix Medical (MD) in Q2 2017, closing a stake of 488,472 shares — an estimated $33.9M sold.

Polar Capital first reported a position in MD in Q4 2013 and held it in 6 quarters. The position peaked at $33.9M in Q1 2017. 332 funds tracked by Wall St. Rank hold MD as of Q2 2017.

Polar Capital reported no remaining Pediatrix Medical position as of Q2 2017 after selling out during the quarter.
Polar Capital sold 488,472 Pediatrix Medical shares in Q2 2017, an estimated $33.9M.
Polar Capital first reported a position in Pediatrix Medical in Q4 2013 and held it in 6 quarters.
Polar Capital's Pediatrix Medical position peaked at $33.9M in Q1 2017.
332 funds tracked by Wall St. Rank held Pediatrix Medical as of Q2 2017.

Based on Polar Capital's 13F filing for Q2 2017, filed 14 Aug 2017.